Literature DB >> 17523193

Propriospinal myoclonus: utility of magnetic resonance diffusion tensor imaging and fiber tracking.

Emmanuel Roze1,2, Emmanuelle Apartis3,4, Marie Vidailhet1,5, Valérie Cochen1,5, Yara Beaugendre3,6, Jean-Marc Trocello1,3,4, Pierre Lasjaunias7, Denis Ducreux7.   

Abstract

Propriospinal myoclonus (PSM) is a rare movement disorder characterized by involuntary spinal-generated muscular jerks that spread rostrally and caudally to other spinally innervated muscles. Most patients have no clear etiology, and conventional MRI of the spinal cord is generally normal. Here we report the use of magnetic resonance diffusion tensor imaging (DTI) and fiber tracking to detect tract-specific abnormalities in a patient with propriospinal myoclonus. As the patient had the fragile-X premutation and antithyroid antibodies, spinal cord DTI abnormalities may be related to these conditions. Tract-specific analysis may provide new insights into the pathophysiology of propriospinal myoclonus. Copyright 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2007        PMID: 17523193     DOI: 10.1002/mds.21562

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

1.  High-resolution and functional magnetic resonance imaging of the brachial plexus using an isotropic 3D T2 STIR (Short Term Inversion Recovery) SPACE sequence and diffusion tensor imaging.

Authors:  M Viallon; M I Vargas; H Jlassi; K O Lövblad; J Delavelle
Journal:  Eur Radiol       Date:  2008-01-08       Impact factor: 5.315

2.  Myoclonus.

Authors:  Victoria C Chang; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 3.  Propriospinal myoclonus: clinical reappraisal and review of literature.

Authors:  Sandra M A van der Salm; Roberto Erro; Carla Cordivari; Mark J Edwards; Johannes H T M Koelman; Tom van den Ende; Kailash P Bhatia; Anne-Fleur van Rootselaar; Peter Brown; Marina A J Tijssen
Journal:  Neurology       Date:  2014-10-10       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.